Royal Bank of Canada
RPID icon

Royal Bank of Canada’s Rapid Micro Biosystems RPID Stock Holding History

Royal Bank of Canada’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-719
Closed -$2K – 7741
2026
Q1 		$2K Buy
+719
New +$2.63K ﹤0.01% 6753
2024
Q3 		– Sell
-442
Closed – – 7354
2024
Q2 		$0 Buy
442
+382
+637% +$327 ﹤0.01% 7464
2024
Q1 		$0 Sell
60
-190
-76% -$185 ﹤0.01% 7512
2023
Q4 		$0 Buy
+250
New +$256 ﹤0.01% 7513
2023
Q3 		– Sell
-339
Closed – – 7506
2023
Q2 		$0 Buy
+339
New +$343 ﹤0.01% 7605
2022
Q4 		– Sell
-35
Closed – – 7641
2022
Q3 		$0 Buy
+35
New +$136 ﹤0.01% 7789
2022
Q2 		– Sell
-976
Closed -$7K – 7665
2022
Q1 		$7K Sell
976
-1,020
-51% -$7.51K ﹤0.01% 7124
2021
Q4 		$21K Buy
1,996
+1,130
+130% +$17.6K ﹤0.01% 6788
2021
Q3 		$16K Buy
+866
New +$17.9K ﹤0.01% 6790

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $8.55M AUM 12.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EFA
Evernest Financial Advisors Carmel, Indiana $478M AUM 24% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Royal Bank of Canada's RPID Position: Q2 2026 in Review

Royal Bank of Canada sold out of Rapid Micro Biosystems (RPID) in Q2 2026, closing a stake of 719 shares — an estimated $2K sold.

Royal Bank of Canada first reported a position in RPID in Q3 2021 and held it in 9 quarters. The position peaked at $21K in Q4 2021. 34 funds tracked by Wall St. Rank hold RPID as of Q2 2026.

  • Royal Bank of Canada reported no remaining Rapid Micro Biosystems position as of Q2 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 719 Rapid Micro Biosystems shares in Q2 2026, an estimated $2K.
  • Royal Bank of Canada first reported a position in Rapid Micro Biosystems in Q3 2021 and held it in 9 quarters.
  • Royal Bank of Canada's Rapid Micro Biosystems position peaked at $21K in Q4 2021.
  • 34 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.